Podcasts about National Eye Institute

Dr. Jacqueline Barry is the Chief Clinical Officer at Cell and Gene Therapy Catapult, Dr. Kapil Bharti is a Senior Investigator at the National Eye Institute at the National Institutes of Health, and Dr. Jack Mosher is the Scientific Director at the International Society for Stem Cell Research (ISSCR). They discuss their work on the ISSCR's Best Practices for the Development of Pluripotent Stem Cell-Derived Cellular Therapies. They talk about the need for consistency and rigor in cell therapy development, and how the document can be navigated and applied across jurisdictions.

Texas Tech Now reports that two Texas Tech Clinical Psychology professors: Adam T. Schmidt and Sarah Victor are conducting a study on blind and visually impaired children. The study examines the kids' experiences around their families, peers, schools, and other settings. The professors earned an over $3,000,000 grant from the National Eye Institute for the study. Sarah and Adam join us to talk about the study.      For more info related to this week's show, go to: https://speakingoutfortheblind.weebly.com/list-of-episodes-and-show-news/for-more-information-episode-357-impacts-of-visual-impairments-on-children Ways to Connect to Speaking Out for the Blind Amazon Alexa enabled device (RECOMMENDED) “Alexa, Ask ACB Media to play Media 1”. (1 = stream number).   PC / browser access (RECOMMENDED): Visit acbmedia.org at http://www.acbmedia.org/1 (1 = stream number). The site has a built-in media player and there is no need to install or use a media player on your device. Hit the play button and the stream will begin playing immediately. Smart device Access (RECOMMENDED): Download “ACB Link” from your app store. Find “Radio” along the bottom of the screen, then “Menu” in the top left corner. Select “Live Streams” and then choose “ACB Media 1 - Mainstream.” Double tap the play button. Victor Reader Stream Access: Navigate to “Internet radio library” in the “online bookshelf”. Locate the Humanware playlist. From the playlist, select ACB Media 1 (1 = stream number) and hit play.   Alternate Dial-In access Dial 1 (518) 906-1820. Listen to the menu prompts and press 1. IMPORTANT NOTE The ACB Radio Tuner is no longer supported. If you used the tuner in the past, you may access all ACB Media streams from acbmedia.org (see above) If you are using alternate ways to access ACB Media streams than those above (such as Tune In or Winamp using acbradio.org URL's, we kindly ask that you use one of the methods above.   Facebook page is at Speaking Out for the Blind and X (formerly Twitter) page is at SpeakOutfortheBlind (you may also access this at SpeakOutBlind).

Why is peer review important? Is AI changing peer review? How can you become a better peer reviewer? Find out in this special episode, with our newest host and Social Media Editor, Dr. Emily Schehlein, and Dr. Matilda F. Chan. Dr. Chan, in collaboration with editors of several ophthalmic and optometric journals and the National Eye Institute, administers the new Council of Vision Editors Fellow Program designed to train early career vision scientists on the peer-review process. The Academy's family of journals is a proud participant in the mentoring program. For more, read Dr. Chan's editorial in Investigative Ophthalmology & Visual Science, “Peer Review in Ophthalmology: A Collaborative Approach to Training the Next Generation of Reviewers.”

Send us your feedbackNew research has found that taking a daily vitamin and mineral supplement can slow the progression of late-stage dry age-related macular degeneration (AMD), otherwise known as geographic atrophy (GA).Dr Tiarnan Keenan from the National Eye Institute joins us to discuss these new findings in more detail and answer your questions.Previously, supplements, based on the AREDS2 formula, have only been recommended for those with the earlier stages of AMD. Listen to learn how this promising discovery could help maintain vision and independence longer for those with late-stage dry AMD.The Macular Society has been supporting people with macular conditions for over 30 years. The right information and support can help people overcome their worries and retain their independence. We provide free information and support to those with macular disease, along with their family and friends. If you or a family member need advice or support, please make sure to reach out. No one has to face macular disease alone. Please call us on 0300 3030 111.

On today's episode, we sit down with Dr. Michael Chiang, director of the National Eye Institute, to talk all things NEI.   

Dr. Sherrol Reynolds has three key passions: diversity and representation, mentorship, and high-quality eye health care. This has led her to become a strong voice in optometry focused on advocating for the profession's role in overall healthcare with a goal of increasing communication and collaboration between optometrists and other members of their patients' healthcare team. She has won numerous awards and held several key leadership positions for the National Optometric Association, Optometric Retina Society, the National Eye Institute, Prevent Blindness, and the Florida Optometric Society. As a leader in diabetes and diabetic retinopathy education, she is changing the narrative for patients with diabetes and their healthcare providers so that no one unnecessarily loses their vision due to diabetes like her aunt did. Ultimately, she wants every human to have access to high-quality healthcare.  Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

In this episode of Seeing Clearly, Emaan Chaudry and Danielle Solish talk to Dr. Matthew Benson, a clinician-scientist in the Department of Ophthalmology and Visual Sciences at the University of Alberta.  Dr Benson, specializes in ocular genetics and adult strabismus and he runs a translational research lab that investigates disease mechanisms in inherited retinal disorders. He completed his medical school and ophthalmology residency training at the University of Alberta, and then completed a clinical fellowship in ocular genetics at the National Eye Institute at the National Institutes of Health. In addition to his medical and surgical practice and research interests, Dr. Benson is actively involved in mentoring medical students, graduate students, residents, and fellows. In this episode, we discuss: Dr. Benson's journey to and within ophthalmology. Dr Benson's fellowship in ophthalmic genetics. Dr Benson's life as a clinician scientist and the importance of research in ophthalmology. Dr Benson's advice for learners. Check out our website: www.eyecurriculum.com  Follow us on Instagram: www.instagram.com/EyeCurriculum  Follow us on Twitter: www.twitter.com/EyeCurriculum 

In this special 2023 Society for Neuroscience Meeting, Lesley discusses the experience of attending the SfN conference for the first time with postbaccalaureate at the National Eye Institute, Alexis Green; presenting a poster and developing connections at SfN with postdoctoral researcher at MPFI, Dr. Tim Holford; and further discuss new insights in Obsessive Compulsive Disorder (OCD) research with Professor, and Associate Dean for Academic Affairs at Stanford University School of Medicine, Dr. Carolyn Rodriguez. Episode Guests: Alexis Green Tim Holford Carolyn Rodriguez @CRodriguezMDPhD https://med.stanford.edu/rodriguezlab Do you enjoy watching the podcast? Feel free to like this episode and follow us to hear more. Max Planck Florida's Neurotransmissions Podcast Website: www.mpfi.org/news-media/podcast Social Media: @MPFneuro Twitter: twitter.com/MPFNeuro Instagram: www.instagram.com/mpfneuro Facebook: www.facebook.com/MPFNeuro Episode host: Lesley @Colgan_Lesley Visit www.mpfi.org/ for more information about the Max Planck Florida Institute for Neuroscience

Episode 151: Martian Medicine 102Future Dr. Collins discussed with Dr. Arreaza two common complications of astronauts in a hypothetical travel to Mars: Spaceflight-Associated Neuro-ocular Syndrome and mental illness.  Written by Wendy Collins, MSIV, Ross University School of Medicine. Comments by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Arreaza: We are back for another episode of Martian Medicine! A couple months ago we published the episode Martian Medicine 101. We talked about radiation and its health risks for astronauts going beyond Low Earth Orbit such as a crew going to Mars. Today, we are going to be covering Martian Medicine 102, where we discuss some more risks from the article “Red risks for a journey to the red planet”. So, let's just jump into it! The next risk we are going to talk about is Spaceflight-Associated Neuro-ocular Syndrome or SANS.  Wendy: Yes, so this used to be called Vision Impairment Intracranial Pressure because the syndrome affects astronauts' eyes and vision and can appear like idiopathic intracranial hypertension. But the name changed to SANS because is not associated with the classic symptoms of increased intracranial pressure in idiopathic intracranial hypertension such as severe headaches, transient vision obscurations, double vision, and pulsatile tinnitus. Also, it has never induced vision changes that meet the definiti on of vision impairment, as defined by the National Eye Institute. Its name change also reflects that the syndrome can affect the CNS well beyond the retina and optic nerve. Arreaza: Let's talk about SANS some more. SANS presents with an array of signs including edema of the optic disc and retinal nerve fiber, and what else?Wendy: Edema of chorioretinal folds, globe flattening, and refractive error shifts. Flight duration is thought to play a role in the pathogenesis of SANS, as nearly all cases have been diagnosed during or immediately after long-duration spaceflight such as missions of 30 days duration or longer. But signs have been discovered as early as mission day 10. SANS has been studied in ISS crewmembers who are tested with optical coherence tomography (OCT), retinal imaging, visual acuity, a vision symptom questionnaire, Amsler grid, and ocular ultrasound.Arreaza: About 69% of the US crewmembers on the ISS experience an increase in retinal thickness in at least one eye, indicating the presence of optic disc edema. This can cause an astronaut to experience blind spots and reduced visual function. Fortunately, to date, blind spots are uncommon and have not had an impact on mission performance.Wendy: And chorioretinal folds if severe enough and located near the fovea, an astronaut can experience visual distortions or reduced visual acuity that cannot be corrected with glasses or contact lenses. Fortunately, and despite a prevalence of 15–20% in long-duration crewmembers, chorioretinal folds have not yet impacted astronauts' visual performance during or after a mission.  Arreaza: A change in your glasses prescription is due to a change in the distance between the cornea and the fovea, and it occurs in about 16% of crewmembers during long-duration spaceflight. This risk is reduced by giving crewmembers with several pairs of “Space Anticipation Glasses” (or contact lenses). The crewmember can then select the appropriate lenses to correct visual acuity. Wendy: From a longer-term perspective, SANS presents two main risks to crewmembers: optic disc edema and chorioretinal folds. It is unknown if a multi-year spaceflight like that to Mars will be associated with a higher prevalence, duration, and/or severity of optic disc edema compared to what has been experienced onboard the ISS. Since the retina and optic nerve are part of the CNS, if optic disc edema is severe enough, the crewmember risks a permanent loss of optic nerve and retinal nerve fiber tissue and thus, a permanent loss of visual function. But again, no astronaut has experienced SANS-related permanent vision loss and choroidal folds usually improved post-flight in affected crewmembers. Arreaza: It is important to understand the pathogenesis of SANS. In microgravity, fluid can distribute uniformly. The fluid that normally pools in your legs due to gravity can now move to your head and cause congestion of the cerebral veins. The pathophysiology of SANS is that CSF outflow can be blocked, which increases intracranial pressure. Wendy: There can be confounding variables such as exercise, high-sodium dietary intake, and high carbon dioxide levels. It is difficult to know much about SANS because there are not many crewmembers who have completed long-duration spaceflight. There is now enough evidence to state that SANS is not a male-only syndrome. Optical Coherence Tomography (OCT) has been used on the ISS since 2013, and it has allowed NASA to build a database of retinal and optic nerve images to understand SANS better. Research from this has shown that most long-duration astronauts present with some level of optic disc edema.Arreaza: Now all NASA crewmembers receive pre- and post-flight MRIs of the brain. There is evidence that brain changes structure with longer space flights. For example, the ventricles of the brain enlarge with 2–3 mL of CSF in astronauts. Luckily, there has been no cognitive problems with this. Like with most space health concerns, more research is needed. Wendy: In summary, SANS is a red risk and top priority to NASA and the human research program. The main concern with SANS is optic disc edema because it could lead to permanent vision impairment. And choroidal folds are also concerning for both short- and long-term flights. But for now, loss of visual acuity is successfully combatted with glasses. Certainly, the more astronauts and flights we take, the more we will learn about SANS.Wendy: Sorry we took so long on SANS, it's probably one of my favorites of all the red risk. Now let's move onto the red risk that includes behavioral health and performance. Future long duration mission in which you are in an isolated and confined space such as a space craft surrounded by an inhospitable environment which humans are not meant to survive could be a problem for the crew's behavioral and mental health. Arreaza: This could affect the astronauts and their ability to complete their mission. Typically, astronauts enjoy space and report it is a positive experience. But psychological changes from being in space for a long time will likely be even more challenging. Wendy: In the past, astronauts have reported ‘hostile' and ‘irritable' crew and symptoms of depression. Arreaza: Stressors to the ISS include long work hours and high workload, and the discomfort of space motion sickness. No one likes vomiting.  Wendy: Being on the ISS, you are close to Earth, and it is easy to communicate with family and friends when needed. Going to Mars there will be communication delay and will make support more difficult. Astronauts on the ISS also have routinely received care packages, which will also not be available to boost morale. Crew members can also change by swapping out astronauts over a certain period, but the crew to Mars will also not have this ability to work with new people.  Arreaza: There are simulation projects to test human resilience. NASA does these kinds of testing at the Johnson Space Center. There is also research in Antarctica that has shown decreased mood and increased stress for scientists in extreme environments. There is also the Mars 500 mission.  Wendy: Yes, the Mars 500 mission was where a crew of 6 went into isolation in Moscow for 520 days to simulate a trip to Mars. The astronauts had to complete behavioral questionnaires weekly. One of the six reported depressive symptoms based on the Beck Depression Inventory. Two crew members who had the highest ratings of stress and exhaustion, also reported conflicts and sleep difficulties. Two crew members reported no adverse behavioral symptoms during the mission.Wendy: So, I believe we're done. We've covered Radiation, SANS, and behavioral health. I know this topic is probably unique for qWeek, but a lot of what we learn medically from our time in space does have applications to us on Earth. As a medical student advice, I have gotten from others in the field is pursue what you're passionate about. Aerospace medicine is a growing field for clinicians from all specialties, so there's no golden path to take. If you are interested more in this field, I highly recommend joining relevant associations specifically AsMA and AMRSO. And if you ever want to discuss aerospace medicine further, feel free to reach out to me at my Ross email!______________________Conclusion: Now we conclude episode number 151, “Martian Medicine 102.” Future Dr. Collins explained that ocular issues are a potential problem when astronauts go to Mars, including Spaceflight-Associated Neuro-ocular Syndrome and vision impairments that would require changes in glass prescription, so, don't forget to take extra pairs of glasses when you go to the red planet. Dr. Arreaza also joined the conversation by talking about the mental health challenges that many astronauts may face as they embark on a long trip to Mars in a secluded spacecraft. We look forward to more information on Martian Medicine as primary care on Mars may look surprisingly similar to primary care on Earth.This week we thank Hector Arreaza and Wendy Collins. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Patel, Z.S., Brunstetter, T.J., Tarver, W.J. et al. Red risks for a journey to the red planet: The highest priority human health risks for a mission to Mars. npj Microgravity 6, 33 (2020). https://doi.org/10.1038/s41526-020-00124-6Royalty-free music used for this episode: Space Orbit by Scott Holmes, downloaded on July 20, 2022, from https://freemusicarchive.org/music/Scott_Holmes/. 

As school starts up in the next few weeks, more young children will head to the classroom with blurry vision.Nearsightedness is increasing in kids at an alarming rate. The medical term is myopia, a condition in which people can see close objects clearly, but faraway objects, like a whiteboard across the classroom, are blurry.The trend toward myopia decades in the making and worldwide, but it increased during the pandemic, which suggests more time on screens and less time outdoors might be part of the problem. With the rise in nearsightedness, there's been a rush to develop treatments that can slow it down, including eye drops and special contact lenses.MPR News host Angela Davis talks about why today's kids are growing up with worse vision than their parents and also eye health across our lives.What common problems threaten our vision as we grow older and what are the treatments and habits that can keep our vision sharp as we age?   Find information about free and low-cost eye care at the National Eye Institute webpage. Low income families can also receive free eye care tests and other assistance from The Vision Project at the Minnesota Eye Foundation. Guests:  Dr. Mary Gregory is a board-certified optometrist based in Monticello, Minn., who specializes in children's vision and learning.Dr. Derek Horkey is an ophthalmologist with St. Paul Eye Clinic who does comprehensive eye care for adults. He has additional expertise in treating glaucoma.Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Google Podcasts, Spotify or RSS.Use the audio player above to listen to the full conversation.    

For over 50 years, the National Eye Institute (NEI) has been a driving force for cutting-edge vision research, education, and public health guidance. In this episode, we speak with Dr. Michael F. Chiang, Director of the National Eye Institute. A pediatric ophthalmologist by training, Dr. Chiang's work focuses on the application of biomedical informatics to ophthalmology, in areas ranging from telehealth to artificial intelligence to health data management. Over the course of our conversation, Dr. Chiang describes the elegant intricacies of the human eye, shares what excites him most about digital health, discusses the urgent need for reformation in medical education, and shares his mission as the leader of the nation's foremost agency for promoting eye health.In this episode, you will hear about:Dr. Chiang's upbringing in a family of engineers and eventual path found to ophthalmology - 2:22How the practice of ophthalmology is changing and the role of informatics in this change - 6:43What pediatric ophthalmology entails, and why this work inspires Dr. Chiang to this day - 10:39The mechanical intricacies of the human eye - 14:20Dr. Chiang's reflections on how his education in engineering shapes the way he practices medicine - 18:03The importance of patient stories and how modern clinical practice leaves little time for them -  22:55How artificial intelligence is changing medicine and what that means for the future role of doctors - 25:55What excites Dr. Chiang most about the future of medicine, and what concerns him the most - 33:40Dr. Chiang's vision for the National Eye Institute - 44:10Advice to young clinicians on lifelong curiosity and adaptiveness - 46:04In this episode, we discuss Marshall McLuhan's aphorism “the medium is the message” and the subsequent work of Neil Postman on “medium as metaphor.”You can follow Dr. Chiang on Twitter @NEIDirector.Visit our website www.TheDoctorsArt.com where you can find transcripts of all episodes.If you enjoyed this episode, please subscribe, rate, and review our show, available for free on Spotify, Apple Podcasts, or wherever you get your podcasts. If you know of a doctor, patient, or anyone working in health care who would love to explore meaning in medicine with us on the show, feel free to leave a suggestion in the comments or send an email to info@thedoctorsart.com.Copyright The Doctor's Art Podcast 2023

Applications of the metaverse go far beyond gaming and social media. In healthcare and life sciences, innovative physicians and researchers are exploring its potential to accomplish the following: Enhance decentralized clinical trialsDevelop precision medicine therapiesImprove surgical navigation e.g., to perfect a surgical route before treating the patientEnhance surgical education, training, and mentoringAs part of connected care and virtual careTo create medical storefronts Because ophthalmology is considered one of the most innovative fields in medicine, it's no surprise physicians are discussing ways to use this alternate community to enhance clinical care. In this podcast, three ophthalmology thought leaders explore what's possible for eye care in the metaverse. They discuss how digital twins can enable precision medicine. They discuss its application for visual field testing and its potential to identify disease earlier to enable proactive care. Listen to the podcast today to discover: What lies ahead for precision medicine?How will digital twin virtual models enable more tailored treatments? What's possible? What's already in the works?What is the benefit of the metaverse and digital twins on decentralized clinical trials?How are surgeons using augmented reality and virtual reality, as well as a new device called PillBot?How do we gauge clinical performance and metrics in the metaverse?If we can monitor patients in the metaverse, can we enhance or augment their capabilities in that reality?How will this technology help democratize medical education and medical care?How will the metaverse enable better collaboration and communication among physicians, clinicians, and researchers? Panelists:Michael F. Chiang, MD, Director, National Eye Institute, National Institutes of HealthPam Nesbitt, Global Chief Architect for Healthcare & Life Sciences, MicrosoftKhizer Khaderi, MD, MPH, Founder & Director, The Human Perception Lab at Stanford; Founder & CEO, VizzarioRanya Habash, MD, Co-Founder, MΞTAMΞD; FDA Digital Health Network of Experts; Medical Director, Technology Innovation, Bascom Palmer Eye Institute; Visionary Innovation Mentor, Stanford University

Co-hosts Yolanda Fintschenko (Startup Tri-Valley) and Lynn Naylor (Innovation Tri-Valley Leadership Group) continue the Startup Tri-Valley #GameChangers podcast series with a conversation with IrisVision CEO and co-founder, Ammad Khan.  Videos illustrating the transformational power of IrisVision for people with low vision on their YouTube channel   that includes a powerful user reaction video you don 't want to miss. In October of 2022,  Ammad Khan also become the Founder and CEO of Radius XR, a vision health platform that pioneered a new standard of vision diagnostics making routine vision care accessible to everyone. Prior to IrisVision, Ammad founded and served as CEO of CitrusBits, a mobile app agency that creates award-winning mobile technology and applications for global brands such as Mercedes-Benz, Burger King, Quiksilver, Symantec, and Sotheby's. Ammad's experience spans a variety of companies at the intersection of medicine and technology, where he has led the company's mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Jeff Ostroff speaks with Kira Baldonado, Vice President of Public Policy and Health at Prevent Blindness. Kira brings two decades of public health advocacy and leadership experience to the conversation. In this episode, Kira shares her current public policy and advocacy efforts and how it affects people with MacD, your families, and other caregivers. She explores how you can use your voice and your vote to support changes in healthcare. Prevent Blindness is an organization that takes a public health approach to vision and eye health. They are focused on providing early detection of vision problems, getting people access to care, and helping those who may have experienced vision loss experience a high quality of life. Their key focus is Education, Advocacy, and Empowerment. Kira shares how her inspiration evolved over the two decades she's worked at Prevent Blindness. First, as a mother advocating for early childcare vision screening for her son and his preschool peers; then later in life, as family members experienced vision loss due to diabetes-related eye disease. Jeff opens up about his own experiences with diabetes and the importance of annual eye exams.  Next, Kira discusses the collaborative research initiatives between The SupportSight Foundation and Prevent Blindness. The two organizations worked together on a clinical research survey, called Mosaic, which aimed to understand how MacD impacts individuals and their caregiver, many of whom are spouses and family members. Next, Jeff pivots to federal policy changes under Medicare, something many of you have a vested interest in. Kira critiques the 2022 Build Back Better Act for not including vision and hearing care coverage under Medicare. She highlights, “We all need to use the power of our voice through voting to make sure we have individuals in the legislature that understand the importance of more comprehensive access to healthcare.” She mentions that access for Assistive Technology devices is particularly restrictive due to laws currently in place. They are fighting to change that. On the topic of health care, Prevent Blindness centers public health research and community-level interventions, with funding through organizations like the Center for Disease Control and Prevention and the National Eye Institute. Beyond the clinical research, Prevent Blindness looks to get early detection practices, education initiatives, and care for communities in need. She places a strong emphasis on using the data to understand what communities are benefiting from vision care access, and where more support is needed.  Kira then expands on another community initiative called Aspect--a patient engagement program that offers training that empowers you to share your story of vision loss, or caretaking, with key stakeholders to improve clinical trials and care. Kira says, “It's the story of the individual that the speaks loudest in the room to drive change.” Kira and Jeff end part 1 of the episode by exploring the need for a balanced approach to public health research and greater funding. One that not only focuses on the new developments in scientific discovery, but also examines which populations are benefiting and which populations are underserved. Stay tuned for next week's part 2!Recommended Resourceshttps://preventblindness.org/http://www.supportsight.org/http://www.mymacdlife.org/https://www.vispero.com/https://www.freedomscientific.com/https://www.freedomscientific.com/products/lowvision/omnireader/https://www.enhancedvision.com/https://us.optelec.com/https://www.healthyvisionassociation.com/https://www.novartis.com/https://www.centricbank.com/https://www.hinklestein.com/https://www.maculardegeneration.net/https://www.mymacularjournal.com/https://www.facebook.com/groups/mymacularjournal/https://www.health-union.com/Support this podcast at — https://redcircle.com/mymacdlife-macular-degeneration-podcast/donations

In this episode of Seeing Clearly, Emaan Chaudry and Danielle Solish talk to Dr. Nupura Bakshi, a medical retina and uveitis specialist and Associate Professor in the Department of OPhthalmology and Vision Sciences at the University of Toronto. After residency training at the University of Toronto, Dr. Bakshi completed fellowships in both Retina and Uveitis at the National Eye Institute, National Institutes of Health, Bethesda, Maryland. Dr. Bakshi has a special interest in medical and surgical education, and advancing equity, diversity and inclusion (EDI) in medicine. She is serving as the inaugural Chair of the EDI Working Group for the Canadian Ophthalmological Society (COS). She is the Vice Chair of Clinical Services and Quality for the Department of Ophthalmology and Vision Sciences and is a member of the Diversity Advisory Council for the Temerty Faculty of Medicine at the University of Toronto. She has won multiple teaching awards for her efforts in training residents and fellows. In this episode, we discuss: Dr Bakshi's journey to ophthalmology. What being a retina and uveitis specialist entails. A glimpse into what Dr Bakshi's weekly schedule looks like. Dr Bakshi's roles as the chair of the COS EDI Planning committee. Dr Bakshi's advice for learners. Check out our website: www.eyecurriculum.com Follow us on Instagram: www.instagram.com/EyeCurriculum Follow us on Twitter: www.twitter.com/EyeCurriculum

Episode 30 is a special segment featuring Dr. Keith J Wroblewski, who is a retired colonel from the US Army and an associate professor as well as Vice Chair of Education at the George Washington University department of Ophthalmology. As we discuss Dr. Wroblewski's work in both military medicine and the civilian world, we want to also thank all the armed men and women in uniform who put their lives on the line so that our nation could be safe each and every day. Dr. Wroblewski is originally from Pittsburgh, Pennsylvania. He obtained his undergraduate degree from the United States Military Academy at West Point, New York and served four years with the 4th Infantry Division at Fort Carson, Colorado as an Infantry Officer. Dr. Wroblewski then pursued his medical education from Pennsylvania State University College of Medicine after which he trained in ophthalmology from Madigan Army Medical Center in Washington State. After residency, Dr. Wroblewski trained through 2 fellowship subspecialties: 1) Ocular Inflammation and Uveitis at the National Eye Institute in Bethesda 2) Ocular Pathology at the Armed Forces Institute of Pathology. Dr. Wroblewski has served as the chair of Ophthalmology at the Walter Reed Army/National Military Medical Centers and has been the Chief of Surgery at Fort Meade, Maryland serving in the following countries: Korea, Bosnia, Germany, Iraq, and the states of Colorado and Washington. He has also serviced in multiple medical missions inclusive of countries such as Kenya, Mauritania, El Salvador, Honduras, Peru, Trinidad and Tobago, and Guatemala. With an incredible array of experiences, not surprisingly, Dr. Wroblewski has been endowed with many prestigious awards such as the Saint Lucia Medal from the Society of Military Ophthalmology.

Michael Chiang, MD, director of the National Eye Institute, spent more than 20 years in academic research. Now, he leads an organization that supports that research by funding more than 1,500 research and training grants for projects that address vision impairment and blindness.A pediatric ophthalmologist who's board-certified in clinical informatics, Dr. Chiang remains intensely curious and generous. “I succeed when the vision research field succeeds,” he says in this OIS Podcast. With host Sophia Pathai, MD, PhD, Dr. Chiang lays out NEI's recently unveiled strategic plan. The plan hints at where NEI plans to invest its annual $860 million budget over the next five years and how it plans to continue moving forward with its “audacious goals.” Literally, the NEI's Audacious Goals Initiative for Regenerative Medicine was established in 2012 to push the boundaries of retina science and restore vision through retina regeneration. It has funded $80 million in research to date, and there's more work to be done.There's also room to improve diversity, equity, and inclusion in science and medicine—another area Dr. Chiang is passionate about. His mantra for collaboration: Instead of “great minds think alike,” it's “great minds think differently[CN1] .” Follow him @NEIDirector. Listen to this OIS Podcast to discover:More about Dr. Chiang's background, which starts with electrical engineering and continues with ophthalmology and biomedical engineering.What's inside the NEI strategic plan, including its revised mission statement, its “audacious goals,” and its priorities for the next five years.What's involved in developing such a large-scale plan, from buy-in to contributor involvement to change management.How the NEI promotes equal access to care as well as diversity within scientific collaboration.Where he sees room for opportunity in the relationship between academic institutions, industry, investment, and government.How emerging researchers can stay at the leading edge of innovation over the next 10 years.Click “play” to listen.

How did parents and teachers not know that a 15 year old adolescent has been blind since birth? Stephanie discovered that her son who was a high-achieving AP student was blind when he couldn't recognize himself in a family picture. Listen to this episode as a mother describes her journey to get her child the diagnosis of CVI ( Cerebral Visual Impairment). CVI is a medical diagnosis that affects the brain. It's not the typical optical blindness that most people have heard of and are familiar with. According to the National Eye Institute, CVI is the leading cause of vision loss among children in the U.S. To name a few symptoms that individuals can experience are recognizing faces and objects and understanding what they are looking at. This powerful story of love and advocacy brings us awareness and the basic information that can be helpful to educators when working with children. Click the links below and be sure to share this episode with pediatricians, educators, school district health coordinators and with individuals you think will benefit. https://www.nei.nih.gov/about/news-and-events/news/vision-loss-children-whose-eyesight-may-be-2020-requires-new-diagnostic-and-teaching-strategies https://www.optometrytimes.com/view/getting-to-the-heart-of-pediatric-vision-loss-and-blindness https://cviscotland.org/ https://www.aph.org/product/vision-and-the-brain-understanding-cerebral-visual-impairment-in-children/ https://www.perkins.org/our-work/cvi/ https://stephanieduesing.com/ New exciting news! We are on Feedspot's list of the Top Parenting Podcasts! blog.feedspot.com/parenting_podcasts/ MUSIC Look to Listen to Learn By Lisa Navarra & Maryann Buonaspina - www.amazon.com/dp/B074CLC98K/... Train My Brain By Lisa Navarra & Maryann Buonaspina - www.amazon.com/dp/B074CGR87B/... This podcast is presented by Lisa Navarra, Owner of Child Behavior Consulting, LLC. You Can Follow Us On: - www.facebook.com/ChildBehaviorConsulting - twitter.com/LNavarraCBC - www.linkedin.com/company/64563206/ - www.instagram.com/childbehaviorconsulting/ - www.youtube.com/channel/UCWwCxj-Aq469... - www.tiktok.com/@lisanavarraedu - www.tiktok.com/@studentsuccesspodcast - podcasts.apple.com/us/podcast... - open.spotify.com/show/60vi5zx... - music.amazon.com/podcasts/16365f2…ond-expectations

Dr. Thomas V. Johnson III, M.D., Ph.D. (https://www.hopkinsmedicine.org/profiles/details/thomas-johnson) is a glaucoma specialist and the Allan and Shelley Holt Rising Professor in Ophthalmology at Wilmer Eye Institute, at Johns Hopkins University. He is also a member of the Retinal ganglion cell (RGC) Repopulation, Stem cell Transplantation, and Optic nerve Regeneration (RReSTORe) consortium (https://www.hopkinsmedicine.org/wilmer/research/storm/rrestore/index.html), an initiative focused on advancing translational development of vision restoration therapies for glaucoma and other primary optic neuropathies by assembling an international group of more than 100 leading and emerging investigators from related fields. Dr. Johnson received his BA (summa cum laude) in Biological Sciences from Northwestern University in 2005. As a Gates-Cambridge Scholar and an NIH-OxCam Scholar, he earned his PhD in Clinical Neuroscience from the University of Cambridge (UK) in 2010. He completed his medical training (AOA) at the Johns Hopkins School of Medicine in 2014 and served as an intern on the Johns Hopkins Osler Medical Service prior to completing his ophthalmology residency and glaucoma fellowship at the Wilmer Eye Institute. Dr. Johnson's research interests are focused on understanding the pathophysiology of retinal and optic nerve neurodegenerative disorders, and on the development of neuroprotective and neuroregenerative therapies for these conditions. His doctoral thesis work evaluated intraocular stem and progenitor cell transplantation as a possible neuroprotective therapy for glaucoma. His research contributions have been recognized with a World Glaucoma Association Award nomination, the National Eye Institute's Scientific Director's Award, and the Association for Research in Vision and Ophthalmology's Merck Innovative Ophthalmology Research Award. He also founded and served as director of the Student Sight Savers Program, a program that provides vision screening services to low-income residents of Baltimore, and helps them obtain access to clinical ophthalmological care. Presently, Dr. Johnson is interested in the neurobiological processes that lead to retinal ganglion cell death and dysfunction in glaucoma and other optic neuropathies. In particular, he seeks to better understand the molecular mechanisms underlying axonal degeneration, dendrite retraction and afferent synapse loss, and cell body death in glaucoma. His goal is to utilize knowledge of these processes to develop targeted neuroprotective strategies to slow or halt RGC death and preserve vision for patients with glaucoma. He is also leading new investigations into the use of stem cell transplantation to achieve retinal ganglion cell placement, as a potential regenerative treatment for optic nerve disease, with a focus on anatomic incorporation of cell grafts, neurite growth and synapse formation, and electrophysiological retinal circuit integration.

In this episode of The Stem Cell Report, Martin Pera is joined by three experts on the eye, its development, and disease processes.  Dr. Mark Humayun is the Director of the Institute for Biomedical Therapeutics and Co-Director of the Roski Eye Institute at the University of Southern California.  Dr. Anand Swaroop is a Senior Investigator in the Neurobiology, Neurodegeneration and Repair Laboratory at the National Eye Institute, and Dr. Masayo Takahashi is a pioneer in iPS-based approaches to treat eye disease and the President of Vision Care Inc., a venture that will focus on cell-based treatments for macular degeneration and other eye diseases. Today's guests will talk about their respective research and where the field of regenerative medicine for eye disease currently stands and where it is headed. Articles from the guests can be found below in the “Supporting Docs” as is the Virtual Collection of eye-focused papers recently published in Stem Cell Reports.  GuestsMark Humayun, MD, PhD, Keck School of Medicine, University of Southern California, USA Anand Swaroop, PhD, National Institutes of Health, USA Masayo Takahashi, MD, PhD, Vision Care Inc., Japan HostMartin Pera, PhD – Editor-in-Chief, Stem Cell Reports and The Jackson LaboratoryTwitter: @martinperaJAXSupporting DocumentsSurvival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration, Stem Cell Reports Gene therapy of dominant CRX-Leber Congenital Amaurosis using patient derived Retinal Organoids, Stem Cell Reports Stem cells in translation: Eye disease, Stem Cell Reports Virtual Collection  About Stem Cell ReportsStem Cell Reports is the Open Access journal of the International Society for Stem Cell Research (ISSCR) for communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.Twitter: @StemCellReportsAbout ISSCRWith nearly 4,000 members from more than 65 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.Twitter: @ISSCRAcknowledgementsISSCR StaffKeith Alm, Chief Executive OfficerYvonne Fisher, Managing Editor, Stem Cell ReportsKym Kilbourne, Director of Media and Strategic CommunicationsJack Mosher, Scientific AdvisorVoice WorkBen SnitkoffMusic@Konovalov

A native of Baton Rouge, Louisiana, First Sergeant Michael Landry, Founder at One Life Clothing, LLC, appeared on Unarmored Talk to talk about how he serves boldly with blindness in the United States Marine Corps, the challenges he chose to overcome, and what inspires him.Follow Me With 1-Click

Why do we think Atropine works?  If you think it is because of accommodation, think again.  We also discuss concentrations and the studies leading to how I use atropine in my practice.  Also, Jeff speaks about a recent study talking about what your patients will experience when they use atropine.  Jeff's work in the area of Myopia has been so influential in my myopia practice. About Dr. Jeff Walline:Jeffrey J. Walline, OD PhD is the Associate Dean for Research at The Ohio State University College of Optometry. He received his Doctor of Optometry degree from the University of California, Berkeley School of Optometry, and he received his Master's and PhD degrees from The Ohio State University College of Optometry. Dr. Walline has led several pediatric contact lens studies, and he is the Study Chair of the Bifocal Lenses In Nearsighted Kids (BLINK) Study, a National Eye Institute-sponsored randomized clinical trial to investigate the myopia control effects of soft multifocal contact lenses.Where to find Dr. Jeff Walline:Instagram: @jwalline1

Dr. Macrene Alexiades holds three Harvard degrees, a BA in Biology, an MD and a PhD in Genetics; 25+ year research background; and runs her own esteemed Park Avenue private practice in dermatology and laser surgery, a research clinic, and a lab focusing on anti-aging skin care, acne, skin cancer, and lasers. She is an artist and sculptor and uses injectables to achieve a natural look in her patients. M.D., Ph.D. received her three degrees from Harvard University: a B.A. from Harvard University, where she was elected to Phi Beta Kappa and awarded the Fay Prize, the highest undergraduate honor; a M.D. from Harvard Medical School, and a Ph.D. in Geneticsfrom Harvard University. She is Associate Clinical Professor at Yale University and Adjunct Professor at Sigros Hospital, University of Athens. She was a Fulbright Scholar with a research award year in Europe. At Harvard, she excelled in portrait art and sculpture, but ultimately chose medicine and science, and was profiled in The New York Times and Vogue for her artistic skills in dermatology, injections and lasers. In medical school, she was honored with the Harvard Medical School Dean's Report and the Paul Dudley White Award. In graduate school, she received grants from the National Institutes of Health, National Eye Institute and Radcliffe College. As Chief Dermatology Resident at New York University School of Medicine, she was awarded the Husik Prize. She is a Fellow of the American Academy of Dermatology and American Society for Laser Medicine (ASLMS) and Surgery and a Goldman Circle Member. She has achieved the rare status of Double Board-Certification in Dermatology in the European Union as well as the U.S. She is a Castle Connolly Top Doctor, New York Magazine Top Doctor and featured in numerous Who's Who awards. She serves on numerous medical boards, conducts FDA clinical trials for Allergan and research for Lancome among many other pharmaceutical and cosmetic companies. She recently was awarded the Richard E. Fitzpatrick Award, the top laser prize for her research at ASLMS. She is Assistant Editor for the journal Dermatologic Surgery and Senior Associate Editor for the Journal of Drugs in Dermatology, and Editor & Reviewer for over 15 journals, including The New England Journal of Medicine, JAAD, JAMA Dermatology, Journal of Lasers in Medicine and Surgery, Journal of Cosmetic Surgery, British Journal of Dermatology and the Journal of the European Academy of Dermatology and Venereology. She has served as Chair of Research for the American Society for Dermatologic Surgery, Guest Editor-in-Chief of the Annual Laser Issue for the Journal of Drugs in Dermatology, and has been extensively biographed in Who's Who and recipient of the Lifetime Achievement Award and Industry Leaders Award.. --- Send in a voice message: https://anchor.fm/skincareanarchy/message Support this podcast: https://anchor.fm/skincareanarchy/support

Prof Kumaramanickavel works on ocular genomics - primarily involved in gene mapping, mutational screening and association studies including genome-wide in complex and Mendelian ophthalmic diseases. Was involved in glaucoma, diabetic retinopathy and pediatric epidemiological and genetic projects comprising of 35,000 subjects. Was a key member of a successful ocular gene mapping team at New Zealand. Later, joined the Department of Genetics at Sankara Nethralaya, India and worked for over a decade and where he was elevated as executive officer (Medical) and Deputy Director of Research. He has done genetic counselling for over 10,000 patients and teaches medical and ophthalmic genetics. He graduated in medicine (MBBS) from the University of Madras, Madras Medical College, India and subsequently graduated in MD (Physiology). As Fogarty Visiting Associate, Dr. James Fielding Hejtmancik trained him in the Ophthalmic Genetics & Clinical Services Branch, National Eye Institute, National Institute of Health, USA. He was a Research Fellow, Ocular Gene Mapping Laboratory, Department of Biochemistry, University of Otago, New Zealand, where Dr. Michael John Denton trained him. During the same period at Otago, Dr. Robert F Mueller trained him in genetic counselling. Currently, he is the Research Director at two premier ophthalmic institutions of India – (a) Narayana Nethralaya, Bangalore and (a) Aditya Jyot Eye Hospital, Mumbai. He is a visiting faculty at the National Eye Institute, USA; Chinese University of Hong Kong and several universities in China and India. He has received funding for research projects from DBT, DST, ICMR, CSIR (all Government of India), National Institutes of Health, USA, INSERM, France and other private funding agencies. He has over 90 peer-reviewed publications including articles in Nature Genetics. He is a recognized PhD guide in various universities in India and across the world.

About Dr. Andrew Pucker:Dr. Pucker earned his OD, MS, and PhD degrees from The Ohio State University, and he is currently an Assistant Professor and the Director of Clinical Research and Myopia Control at the University of Alabama at Birmingham. Dr. Pucker has been the Principal Investigator of a National Eye Institute funded project related to myopia development, and he currently manages other funded projects related to refractive error, dry eye, and contact lenses. He is a Fellow and Diplomate of the American Academy of Optometry, Fellow of the Scleral Lens Education Society, and Fellow of the British Contact Lens Association. He has also received a number of others honors, which include two William C. Ezell Fellowships, the Irvin M. andBeatrice Borish Award, the Association of Schools & Colleges of Optometry's Rising Star Award, and being named as an Emerging Vision Scientist by the Alliance for Eye and Vision Research.

Aging-US published a Special Collection on Eye Disease which included "PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics" which reported that the PU-91 drug upregulates PGC-1α which is a critical regulator of mitochondrial biogenesis. Since mitochondrial dysfunction is implicated in the pathogenesis of AMD, this study is based on the premise that repurposing of PU 91 might rescue AMD RPE cells from AMD mitochondria-induced damage. The authors report significant improvement in cell survival, mitochondrial health, and antioxidant potential following treatment with PU 91. Dr. M. Cristina Kenney from The University of California Irvine said, "The incidence of Age-related Macular Degeneration (AMD) is increasing at an alarming rate in elderly population in the United States." The incidence of Age-related Macular Degeneration (AMD) is increasing at an alarming rate in elderly population in the United States. Most AMD cases occur among Caucasian Americans, followed by Hispanic and other populations. Despite intensive study, a limited number of FDA-approved treatment options are available for treatment of AMD. National Eye Institute projection, the estimated number of AMD patients is expected to rise to 5.44 million by 2050. PU-91 is a pro-drug that when metabolized is PPARα ligand and which was developed for the treatment of dyslipidemia. The drug is estimated to have seen >5 million-years of patient exposure and remains an effective agent for certain dyslipidemias. These findings demonstrated that PU-91 preserved AMD mitochondrial function and integrity, and protected AMD RPE cybrids against oxidative stress-induced and mtDNA-induced apoptotic cell death. The Kenney Research Team concluded in their Aging-US Research Output, "PU-91 rescues AMD RPE cybrids, and potentially could be repurposed as an FDA-approved drug to prevent/treat AMD. Since it improves mitochondrial function and has already been FDA-approved, the candidate therapeutic PU-91 will be an excellent treatmentoption for AMD. Repositioning of PU-91 will be a smoother transition from lab bench to clinic since the pharmacological profiles of PU-91 have been examined already. Furthermore, because of its extensive safety record it could be potentially prosecuted through NDA more rapidly than a drug-like new chemical entity. Bringing a disease modifying therapeutic to market for the most prevalent form of blindness, AMD, has substantial potential benefit for our aging populations world-wide." Full Text - https://www.aging-us.com/article/102179/text Correspondence to: M. Cristina Kenney email: mkenney@uci.edu Keywords: age-related macular degeneration (AMD), RPE, PGC-1α, RPE, mitochondria, FDA-approved drugs About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research as well as topics beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, cancer, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR among others), and approaches to modulating these signaling pathways. To learn more about Aging-US, please visit http://www.Aging-US.com or connect with @AgingJrnl Aging-US is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls Media Contact 18009220957x105 MEDIA@IMPACTJOURNALS.COM

There is more to color than meets the eye. According to Dr. Bevil Conway, how we perceive color can inform how our brains receive, interpret, and generate knowledge about the world. Dr. Conway is a visual artist and a neuroscientist at the National Eye Institute. He is working to decode the neural basis of color. In a recent study, his lab mapped how different colors can stimulate different patterns of brain activity.

It's "In the News..." the only LIVE diabetes newscast! Top stories this week: FDA hints on 2021 D-tech timeline, the Freestyle Libre 2 app is approved, interchangeable insulin to cost less, an "astonishing" type 2 teen study and a big fall-off in use of metformin in people with type 2. Join us on Facebook live every Wednesday at 4:30pm EDT This week I was on the road, at the Podcast Movement convention. Sorry about the setting! Back in the home studio next week. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Click here for iPhone      Click here for Android Episode Transcription below: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  I'm on the road – again! This time I'm at podcast movement a big convention going on in Nashville.. so apologies if the audio and video are a little bit off but I think we're good enough. And As always, I'm going to link up my sources in the Facebook comments – where we are live – and in the show notes at d-c dot com when this airs as a podcast.. so you can read more when you have the time. XX In the News is brought to you by Real Good Foods! Excited to have them back as a sponsor – we're big fans. Real Food You Feel Good About Eating. XX Our top story this week… a brief comment about diabetes devices at the FDA might give a hint to some timelines we're all watching. FDA Center for Devices and Radiological Health head Jeffrey Shuren says COVID-19 remains a source of uncertainty. "Goal is to be back to normal as we roll into 2022," Shuren said. "But there are a lot of variables that could impact that… don't know if we'll get hit with another tsunami of submissions for full marketing authorization for a lot of the COVID products. Getting back on track, everything is moving for the diabetes submissions." Products in front of the FDA expected by year's end: Medtronic's 780G and Zeus CGM, Insulet's Omnipod 5, Tandem's bolus by phone and it's expected that Dexcom's G7 will be submitted soon. https://seekingalpha.com/news/3715640-fda-devices-head-says-progress-being-made-on-diabetes-devices-backlog XX The FDA did clear one diabetes product this past week.. Abott's Freestyle Libre 2 iOS app. The Libre 2 hardware was approved last year.. this is the app for Apple phones.. it gives users optional real time high and low alarms – still have to scan to see the actual values. It updates every minute – only CGM that does – and it lets caregivers remotely monitor. Freestyle Libre 2 has a 14 day wear.. no exact date on when the App will be available or when it'll be available for android users.   https://finance.yahoo.com/news/abbotts-freestyle-libre-2-ios-130000861.html XX Other side of the coin, Abbot will pay $160 million to resolve claims that two of its units submitted false claims to Medicare. The Justice Department said free glucose monitors were provided to get patients to order more testing supplies, and the companies routinely waived copayments. They were also accused of charging Medicare for ineligible patients and for more than 200 patients who were actually dead. https://www.reuters.com/business/healthcare-pharmaceuticals/us-says-abbott-units-pay-160-mln-resolve-alleged-false-medicare-claims-2021-08-02/ XX Back to the FDA.. for the first time, they're allowing a less expensive brand name insulin to be substituted for the original. Semglee – approved last year – is basically the same as Lantus but it's a lot less expensive. Semglee is now is the first-ever to earn the “interchangeable” designation Trusted Source, meaning it's fully approved to be substituted for Lantus at the pharmacy. No need to get permission from the doctor. This is the second copycat of Lantus; the first was Eli Lilly's Basaglar, launched in 2016. There is some new branding and labeling needed here, so expect a relaunch of Semglee by the end of this year. FYI the pens are a little different even if the insulin in them is the same. It's always a good idea to know what your doctor is prescribing and what your pharmacist is giving you.. even if it costs less. XX Big new studies focusing on children and teens with type 2 diabetes.. showing how different the disease can be in younger people. The studies, published July 29 in the New England Journal of Medicine, showed that within 15 years of a Type 2 diabetes diagnosis, 60% of participants had at least one diabetes-related complication, and nearly a third of participants had two or more. These Texas researchers call it astonishing and say it appears type 2 in youth is much more aggressive than in older people. These researchers say more treatment options are needed for younger people because lifestyle changes don't seem to be enough. The study also showed a lot of families don't have regular access to medication or health care providers. They say it was a diverse study representative of teens and kids in the US. https://medicalxpress.com/news/2021-08-young-adults-complications-diabetes.html   XX More to come, including new about people with diabetes who stop taking a very commonly prescribed medication..  but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible. Real Good Foods! We've been fans for a long time – Benny especially likes their ice cream. Real Good Foods makes delicious food you'll feel good about eating; high in protein, grain free and always made from real, nutrient dense ingredients. The labels are easy to read – because the ingredients aren't chemicals and fillers. Whether it's waffles or burrito bowls or stuffed chicken or the pizza that started it all.. I think you'll really love Real Good Foods. Learn more with the link in the FB comments or as always at d-c dot com. Back to the news…   XX Interesting research using artificial intelligence to catch diabetes eye issues earlier – when they're easier to treat. Changes in the blood vessels in the retina cause diabetic retinopathy, the most common diabetic eye disease and a leading cause of blindness in US adults. There are several studies and institutes looking at the use of A-I here, but these folks at the Indiana University School of Optometry say they're using information that is often ignored for diagnosis and it's making a big difference. The National Institutes of Health's National Eye Institute funded the work. https://www.futurity.org/biomarkers-diabetic-retinopathy-blindness-vision-2604812/ XX Nearly half of adults prescribed metformin after a new diagnosis of type 2 have stopped taking it by 1 year. The fall off is most dramatic during the first 30 days. These researchers say it didn't matter how long the prescription was written for and most who discontinued still had A1C's high enough to still need glucose lowering medication. They say as physicians quote - A lot of times we're quick to prescribe metformin and forget about it...Physicians might write a script for 3 months and three refills and not see the patient again for a year...We may need to keep a closer eye on these folks and have more regular follow-up, and make sure they're getting early diabetes education." https://www.medscape.com/viewarticle/955893 XX That's In the News for this week.. if you like it, please share it! And quick note this is our 400th episode. I've been busy with some behind the scenes stuff and it caught up to me! A huge thank you to all of you.. incredible support from this community. Six years and 400 episodes is an accomplishment that I've only reached because of you. And join me wherever you get podcasts for our next episode -Tuesday –  I'm talking to Eoin Costello the host of his own diabetes podcast – about staying active or starting getting more fit with type 1. This week's interview – the one that's out right now – is a look at the features of Omnipod 5 – the newest hybrid closed loop system in front of the FDA. Thanks and I'll see you soon    

The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.

The month of June is cataract awareness month, so this week on All Home Care Matters, we will be discussing all things cataracts. First, we're going to talk a little about what cataracts are and how you get them, and then we'll move on to what you can do to prevent them. Then, we'll see how to help your loved one manage their cataracts and protect their vision. Now you know what we'll be discussing this episode, let's jump right in.   A cataract is a clouding of the lens in the eye that affects vision and is mostly related to age. According to an article published by the Cleveland Clinic, for your eye to see, light passes through a clear lens behind the colored part of your eye, or the iris. The lens focuses the light so that your brain and eye can work together to process information into a picture. When a cataract clouds over the lens, your eye is unable to focus light in the same way.   By the age of 80, more than 50 percent of all Americans have a cataract or have had cataract surgery. According to Icon Eyecare, to make sure cataracts don't affect your vision, it's important to get regular eye exams - especially if you're over the age of 55.   Cataracts are the leading cause of vision loss worldwide. In a report by the National Opinion Research Center at the University of Chicago, researchers predicted that from 2014 to 2032, the number of cataract cases will increase by 50 percent. Within the next decade, the United States will be faced with one of the biggest healthcare crisis's it has ever had to deal with, and no one seems to be talking about it yet.   The aging population in the United States will reach an all-time high in 2030, when the Baby Boomer Generation will all be 65 or older. With old age, cataracts and other vision problems worsen. Age is the biggest factor in cataracts, but it isn't the only thing that can cause them. There are four other types of cataracts, secondary cataracts, traumatic cataracts, congenital cataracts, and radiation cataracts. Secondary cataracts can form after an eye surgery or develop due to other health problems, like diabetes.   Traumatic cataracts happen after an eye injury. They can happen immediately or even years after the initial injury. Congenital cataracts appear at birth or in childhood and tend to be so small that they do not affect vision. Radiation cataracts can develop after some forms of radiation. All of these types of cataracts can hinder vision and make day-to-day activities difficult. Older adults, as well as everyone else, should see their eye doctor regularly to keep their vision working properly.   The National Eye Institute lists some of the noticeable symptoms of cataracts as: having cloudy or blurry vision, colors looking faded, you are unable to see well at night, lamps, sunlight, or headlights all appear to be too bright, you see a halo around lights, you have to change your glasses prescription often, or you are seeing double of things. Seeing double sometimes goes away as the cataract gets bigger.   Now, this list is somewhat lengthy, but it is in no way exhaustive, and these are not exclusive symptoms of cataracts. All of these symptoms can also indicate a number of other eye problems or diseases. Schedule an appointment with your loved one's eye doctor if they are experiencing any of the above symptoms. Early treatment of any eye disease may just end up saving your loved one's vision.   Cataracts are a common occurrence, and it is very likely that either you or someone you know has a cataract right now. If you think you might be experiencing cataract symptoms or are just wondering what it's actually like living with cataracts, Jim Mathie a former fire chief in Deerfield Beach Florida, speaks about life with cataracts and the difference he noticed as soon as he got them removed at Rand Eye Institute.   “Wow, what a big difference,” Mathie says about his cataract surgery. He goes on to say that the difference is like night and day and he just hadn't realized how bad his vision had been before. He had his surgery on a Thursday and it was so easy he doesn't even remember it. The next day, he went back for an exam and he could see everything. He had so much clarity and was suddenly noticing how vivid all the colors were. He had been getting his yearly eye exams and knew that he had a cataract in one eye. At first, it was manageable, but after five years, he knew it was time to do something about it. He was avoiding driving at night because he assumed it would be an issue. But, what really made him decide to get the surgery was that he was no longer able to enjoy his favorite hobby, diving.   Mathie dove three to four times a week and had started to notice that he was unable distinguish things like fish and lobsters in murkier waters when they were right in front of him. Before his cataract, he had no issues seeing in murky water. He knew it was time to fix his vision, and today he is enjoying his passion, scuba diving, and loving his cataract free life. If you, like Jim Mathie, have noticed your vision deteriorating, or noticed your loved one's vision deteriorating, talk to your eye doctor and see if cataract surgery will work for you.   There are some things we can do while we are younger to prevent cataracts, but cataracts due to aging are not preventable. Cataracts due to age can be fixed or at the very least, the symptoms can be managed, with the help of your doctor. Cataracts caused by other health issues may be prevented by using protection from the sun, such as hats and sunglasses, and eating leafy greens and other fruits and vegetables. Eating a healthy diet will help with many health problems, and not just with cataracts, but I'm sure you already knew that.   If you smoke, quitting smoking will also significantly reduce your chances of getting cataracts. If you are ready to quit smoking, you can call the American Lung Association's Help Line at 1-800-LUNG-USA, that's 1-800 586-4872 today for free help with quitting. You should also talk to your doctor about quitting. They can help you create a plan and track your progress. They can also prescribe medication to help if you need it.   Getting your eyes dilated can also help prevent cataracts. Adults 60 and older should get their eyes dilated at least once every two years. Eye doctors can check for cataracts and monitor existing cataracts while dilating your eyes.   According to aging care dot com, age-related cataracts affect older adults' vision in a few different ways. Clumps of protein build-up reduce the sharpness of the image reaching the retina. The clumps of protein can also cloud the lens and reduce the light that reaches the retina. Over time, the protein can tint the clear lens, turning it a yellow or brownish color, adding a brownish tint to their vision.   Approximately one in five older adults have cataracts. Cataracts are not contagious. If you have a cataract in one eye, you may not develop a cataract in your other eye and you cannot spread them to other people, either.   Depending on the severity of the cataracts, seniors may only need new glasses or a magnifying lens to see better or use brighter lighter at home. Anti-glare sunglasses can help seniors see better while outside or in the car. If none of these options help, surgery is a safe and effective treatment for cataracts.   According to Comfort Keepers, cataract surgery is widely regarded as one of the safest medical procedures. It has a success rate between 95 and 98 percent. For this procedure, the patient usually only needs minimal sedation, which is safer for older adults. Seniors with other health issues are often unable to receive surgeries due to their health conditions but are still able to receive cataract surgeries because of how safe and fast they are. While the risk of complications is low for cataract surgery, it is still important to talk to your doctor about the risks involved.   Cataracts are removed one eye at a time. The senior will have to have the surgery performed on one eye and then wait three to four weeks for the other eye. During this waiting period between surgeries and during the four weeks following the second surgery, senior should try not to rub their eyes or lift heavy objects. They should also continue wearing sunglasses and hats to protect their eyes from the sun.   Once a cataract has been removed, it will not come back. A secondary cataract can form in the same eye, but it is not the original cataract coming back. The secondary cataract can be corrected with a Y A G laser capsulotomy, which is quick and painless.   It is very likely that your loved one has cataracts. They may not even notice any symptoms. If they are experiencing any vision discomfort or other problems, schedule an eye appointment to see if they have any undiagnosed eye conditions. Their doctor can help you make the best course of action for their vision.   Cataracts can make daily activities difficult at first, especially when you are first adjusting to blurry vision. You may notice your loved one being slightly unsteady on their feet or unsure of their movements while they are adjusting to their new stage of vision. They are at a higher risk of a fall during this time, so make sure to remove any obstacles that could hinder their movements and result in a fall.   Your loved one may also need help doing household tasks, like cooking and cleaning, while dealing with cataracts. They may be unable to read a recipe to make their meals and their blurred vision also makes cleaning up messes difficult. Helping your loved one cook meals and clean up around the house, at least until they have either adjusted to their blurred vision or are able to get the cataracts removed, will be extremely helpful to them.   If your loved one has a cataract and you are interested in ways to maintain it without surgery, have them try some eye exercises. Family Vision Development Center says that certain eye exercises can help to strengthen your eyes and ease eye strain. And, while strengthening your eye muscles cannot actually cure cataracts, it can help to slow the progression.   They recommend gently rolling your eyes in a clockwise circle a few times, then reverse to a counterclockwise motion. You can also try moving your eyes from side to side, or in the shape of a figure 8. You can also try changing focus, by focusing on a finger held a few inches from your face, then shifting to an object farther away, then back again.   Learning to live with cataracts can take some time and adjustment. If your loved one is still driving, remind them to be extra cautious and try not to drive at night, as the glare from streetlights can provide hazardous driving conditions for someone with cataracts.   Are you worried about your parent or aging loved one driving, with or without cataracts? You are not alone. In another episode of this podcast, Is Your Loved One Safe Driving, we talked about aging loved ones and what to do when you think they are no longer safe behind the wheel. Please listen to the episode and check out the show notes for resources on safe transportation options and other related driving topics.   Prevent Blindness, the number one volunteer eye health and safety organization, offers free information on cataracts. Their organization has created the Cataract Awareness Month campaign and is very knowledgeable when it comes to cataracts and other causes of vision loss. You can call them at 1-800-331-2020 or visit them on the web at preventblindness.org. Their goal is to eliminate preventable blindness in the United States.   If you or your loved one, or someone you know, is experiencing cataracts and do not have the financial means to fix them, Prevent Blindness may be able to help. Check them out today or send their information to someone in need.   If you are interested in learning about other eye conditions that could be affecting your loved one, listen to our episode on Understanding Glaucoma and visit our website for more information.   Of the five types of cataracts, age-related cataracts are the most common cataracts to be seen, and they disproportionately affect the older population. Losing your vision is frightening and causes your loved one to worry. It is important to let them know that you are there for them during this time and help them perform their daily tasks safely. Make sure your loved one visits their eye doctor regularly so that any vision problems can be caught and fixed before they become a real problem.   Luckily, cataracts can be fixed in a fast and safe procedure, restoring your loved one's sight in a matter of weeks. If they are unable to have the cataracts removed, there are still a few options that can help them see better, like using brighter lights and magnifying glasses. For more information on understanding cataracts in seniors, check out the resources on the show notes for this episode.   We want to thank you for joining us here at All Home Care Matters, All Home Care Matters is here for you and to help families as they navigate long-term care issues. Please visit us at allhomecarematters.com there is a private secure fillable form there where you can give us feedback, show ideas, or if you have questions. Every form is read and responded to. If you know someone is who could benefit from this episode and please make sure to share it with them.   Remember, you can listen to the show on any of your favorite podcast streaming platforms and watch the show on our YouTube channel and make sure to hit that subscribe button, so you'll never miss an episode. Join us next time on All Home Care Matters where we will be sharing Fall Prevention Tips to help keep your loved ones safe.   Sources: https://www.agingcare.com/articles/what-is-a-cataract-age-related-eye-diseases-108282.htm   https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases/cataracts#:~:text=Cataracts%20are%20very%20common%20as,%2C%20hazy%2C%20or%20less%20colorful.   https://iconeyecare.com/eye-care-blog/10-cataract-facts-cataract-awareness-month/#:~:text=June%20is%20National%20Cataract%20Awareness,virtually%20pain%2Dfree%20surgical%20procedure.   https://www.comfortkeepers.com/info-center/category/senior-health-and-wellbeing/article/the-myths-and-facts-of-cataracts-what-seniors-shou   https://my.clevelandclinic.org/health/diseases/8589-cataracts   https://preventblindness.org/cataract-awareness-month-2020/   https://preventblindness.org/wp-content/uploads/2020/04/Future_of_Vision_final_0.pdf   https://www.businessinsider.com/aging-population-healthcare   https://www.lung.org/quit-smoking/i-want-to-quit   https://preventblindness.org/wp-content/uploads/2020/05/CataractRelease2020.pdf   https://www.fvdcpc.com/2021/02/26/simple-strategies-living-with-cataracts/   https://www.bettervision.net/cataracts/5-tips-for-living-with-cataracts/   https://www.randeye.com/after-cataract-surgery-jims-interview-hd/        

When you are focused on something, you’re not blinking much, and our eyes have a muscle inside that flexes when you’re looking up close at something. If you’re spending prolonged periods of time looking at a screen like many of us are right now, you’re flexing this muscle all the time without ever giving it a break. Exhausting!We talk with Dr. Cousineau-Krieger from the National Eye Institute about the increase in eye strain and eye fatigue ophthalmologists have been noticing in the era of COVID-19 when avoiding screens is virtually impossible for many, pun intended.Listen in for great tips like the 20:20:20 strategy to relax your flex muscle and give your eyes a much-needed break when limiting screen time is just not realistic.Visit the National Eye Institute at https://www.nei.nih.gov/ for more tips on eye health.Connect with the Sole Source teamWebsite I Facebook I Twitter I Instagram

What colour is a banana? Is your red the same as mine? How would you describe the colour of the sky at twilight? In this episode, Sienna answers all these questions and more with the help of Dr. Bevil Conway, Shridhar, and Isabelle from the National Eye Institute at the National Institute of Health. Find out why seeing really is un-believing!   https://linktr.ee/notyetadr   Edited by: Alastair   Questions or Suggestions? Email us at phd32b@gmail.com

In this episode, we spoke to Dr. Michael Chiang about his work advancing digital health, from chairing multiple American Academy of Ophthalmology committees to serving as the Director of the National Eye Institute. GUEST CONTACT DETAILS:

In today's episode Dr. Jeff Walline shared with us how to manage Myopia better. About Dr. Jeff Walline: Jeffrey J. Walline, OD PhD is the Associate Dean for Research at The Ohio State University College of Optometry. He received his Doctor of Optometry degree from the University of California, Berkeley School of Optometry, and he received his Master's and PhD degrees from The Ohio State University College of Optometry. Dr. Walline has led several pediatric contact lens studies, and he is the Study Chair of the Bifocal Lenses In Nearsighted Kids (BLINK) Study, a National Eye Institute-sponsored randomized clinical trial to investigate the myopia control effects of soft multifocal contact lenses.Where to find Dr. Jeff Walline:Instagram: @jwalline1

CME credits: 0.25 Valid until: 11-09-2021 Claim your CME credit at https://reachmd.com/programs/cme/national-eye-institute-initiativepractice-strategies-optimize-continuity-care-eye-health-during-covi/11825/ Patients can suffer relapses in their visual acuity if their treatment regimen is not maintained on its defined schedule. Are you taking all necessary steps to prevent disease progression for your patients with diabetic retinopathy (DR), diabetic macular edema (DME), or neovascular age-related macular degeneration (nAMD) during the COVID-19 pandemic? In this discussion, Drs. Diana Shechtman and Charles Wykoff answer key questions and offer solutions related to ensuring the continuity of care for patients with these conditions during and perhaps even after the current pandemic.

CME credits: 0.25 Valid until: 11-09-2021 Claim your CME credit at https://reachmd.com/programs/cme/national-eye-institute-initiative-health-of-patients-and-staff-eye-health-practices-during-covid-19/11826/ Are you doing your part to help prevent the spread of infection while continuing to provide professional services essential to maintain the eye health of your patients? Do you know what best practices have been put in place to continue the care of patients during the COVID-19 pandemic and prevent the transmission of the virus? Are you doing all you can to ensure the safety of your healthcare team and patients? In this activity, Drs. Mark Dunbar and Diana Do discuss important strategies and steps physicians and patients can take to prevent the transmission of COVID-19 while maintaining necessary treatment regimens.

CME credits: 0.25 Valid until: 11-09-2021 Claim your CME credit at https://reachmd.com/programs/cme/national-eye-institute-initiative-health-of-patients-and-staff-eye-health-practices-during-covid-19/11826/ Are you doing your part to help prevent the spread of infection while continuing to provide professional services essential to maintain the eye health of your patients? Do you know what best practices have been put in place to continue the care of patients during the COVID-19 pandemic and prevent the transmission of the virus? Are you doing all you can to ensure the safety of your healthcare team and patients? In this activity, Drs. Mark Dunbar and Diana Do discuss important strategies and steps physicians and patients can take to prevent the transmission of COVID-19 while maintaining necessary treatment regimens.

CME credits: 0.25 Valid until: 11-09-2021 Claim your CME credit at https://reachmd.com/programs/cme/national-eye-institute-initiativepractice-strategies-optimize-continuity-care-eye-health-during-covi/11825/ Patients can suffer relapses in their visual acuity if their treatment regimen is not maintained on its defined schedule. Are you taking all necessary steps to prevent disease progression for your patients with diabetic retinopathy (DR), diabetic macular edema (DME), or neovascular age-related macular degeneration (nAMD) during the COVID-19 pandemic? In this discussion, Drs. Diana Shechtman and Charles Wykoff answer key questions and offer solutions related to ensuring the continuity of care for patients with these conditions during and perhaps even after the current pandemic.

Dr. H. Nida Sen of the National Eye Institute joins the program to discuss uveitis trial design and training uveitis fellows. None of the contributors have any relevant financial disclosures. You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

In this month's episode, we learn that human brains differentiate musical pitch a way that macaque monkeys do not. In fact, speech and music shaped the human brain's hearing circuits. Researchers are studying these circuits with an eye on developing treatments for neurological disorders. Kathryn Loydall from The Scientist's Creative Services team spoke with Bevil Conway, an Investigator at the NIH's National Eye Institute, to learn more. The Scientist Speaks is a podcast produced by The Scientist's Creative Services team. Our podcast is by scientists and for scientists. Once a month, we will bring you the stories behind news-worthy molecular biology research.  If you enjoyed this episode, please subscribe to The Scientist Speaks on your favorite podcast platform.

Let's learn more about color blindness! It's more common than you might think... Dr. Henry Wiley, with the National Eye Institute, joins Amy & JJ to discuss, as he says, "color deficiency". Everything from where does it come from to possible treatments. 

A successful multifocal contact lens strategy makes use of every interaction that a patient has with your office to help promote success. Learn how you can shape this journey to support multifocal success every step of the way. 1. Anderson D. Growth opportunity: tips to move patients into multifocal CLs. Review of Optometric Business. June 7, 2017. 2. Baker K, Merchea M. Impact of pupil diameter on multifocal contact lens vision. Presented at: American Academy of Optometry Annual Conference; November 7-10, 2018. San Antonio, Texas, USA. 3. Alcon data on file, 2018. GLIMPSE de-identified aggregate data. 4. Alcon data on file, 2013. Multifocal motivations: understanding the world of presbyopia. 5. National Eye Institute. Contact Lenses. July 8, 2019.https://www.nei.nih.gov/learn-about-eye-health/healthy-vision/contact-lenses. Accessed April 2, 2020. 6. Pal S. The words we choose to discuss multifocals. Contact Lens Spectrum. 2017;32:28-33.

Drs. Daniel Chao and Ferhina Ali join the podcast for a sneak peek at the January 2020 issue of Retinal Physician (found at http://www.retinalphysician.com) discussing topics such as integration of imaging software with EHR, swept-source OCT angiography applications, intraoperative OCT, and optogenetics. Want to be on the podcast? Now is your chance! Vit-Buckle Society is looking for videos to be presented on the podium during the Complications session of the Annual Meeting in Miami March 26-28 2020. Videos can be identifying or anonymous but should include text descriptions and be 1-4 minutes in length. The top five entries will be invited to come on the podcast for a one-on-one interview discussing the case. Submit entries now to paulapecen@gmail.com or mklufas@gmail.com Dr. Sridhar is a consultant for Alcon, Alimera, and Oxurion. Dr. Ali is a consultant for Genentech and Voyant Biotherapeutics. Dr. Chao is a consultant for Recens Medical, DTXPharma, Allergan, Visgenx, and Zilia and receives research funding from the National Eye Institute, Bright Focus Foundation, Clearside Biomedical Inc., Chengdu Pharmaceuticals, Opthea Ltd, Genentech, and Apellis Pharmaceuticals. You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Dr. Daniel Chung is the global medical strategy lead for ophthalmology at Spark Therapeutics. Spark Therapeutics concentrates on discovering, developing, and delivering gene therapy for rare diseases. Dan works in the area of ophthalmology, and he and his colleagues brought the first FDA-approved gene therapy for a genetic disease to market. This therapy was created to treat an inherited retinal disease that results in blindness and is caused by variants or mutations in the RPE65 gene. When he isn’t working or traveling, Dan enjoys spending time with his family. He is also an avid photographer who loves capturing photos of nature, landscapes, and wildlife. In particular, he has really enjoyed photographing the panoramic landscapes of Monument Valley in Arizona, brown bears in Alaska, and polar bears in Northern Canada. Dan earned both his bachelor’s degree in biology and master’s degree in family counseling from Eastern Nazarene College in Massachusetts. He also holds a doctorate degree in Osteopathic Medicine (D.O.) from the New York College of Osteopathic Medicine. Afterward, Dan became a research training award fellow at the National Eye Institute of the National Institutes of Health, studying retinal gene therapy, and he went on to complete his residency in ophthalmology within the Summa Health System in Ohio. Dan joined the Cleveland Clinic as a pediatric ophthalmology clinical/ocular genetics research fellow and subsequently worked as a senior investigator at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania for eleven years before joining the team at Spark Therapeutics in 2014. In this interview, Dan shares more about his personal and professional passions, as well as his research.

The telephone discussion features Emily Y. Chew, MD, who is a retina specialist and is the deputy director of the Division of Epidemiology and Clinical Applications, and the deputy clinical director at the National Eye Institute (NEI), National Institutes of Health (NIH). Dr. Chew has extensive experience in age-related eye diseases, and designing and implementing clinical trials, including the Age-Related Eye Disease Study 2 (AREDS2).

 Dr. Tamer Mahmoud joins the program to discuss his team’s recent publication on autologous retinal transplantation for large full-thickness macular holes, as well as career advice for fellow and young attendings. Dr. Mahmoud has received grant support from Roche, Novartis, Thrombogenics, and the National Eye Institute. Dr. Sridhar has received fees for consulting for Alimera, Alcon, and Thrombogenics. Some podcast episodes now qualify for CME credits. To claim your credits visit  https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Shannon talks to the National Eye Institute's Dr. Rachel Bishop about eye health, common eye problems, and how we can take better care of our eyes in a preventative manner. Dr. Bishop is the Chief of the Consult Service Section of the Office of the Clinical Director at the National Eye Institute, part of the National Institutes of Health, which is part of the Department of Health and Human Services. She performs eye examinations on patients who are participating in clinical trials throughout the many Institutes and Centers at the National Institutes of Health. Dr. Bishop received her medical degree from the University of Pennsylvania School of Medicine. She completed her medical internship and ophthalmology residency at Walter Reed Army Center. She holds a Master’s of Public Health from Johns Hopkins. She also has a distinguished military career and provided eye care to thousands of soldiers before or after their deployment to Afghanistan and Iraq, as chief of ophthalmology at Darnall Army Community Hospital in Fort Hood, Texas. The Authentic Woman with Shannon Fisher explores personal, political, and societal perspectives of the American experience. The show delves deeply into the worlds of writers, artists, celebrities, and community leaders and offers listeners food for thought on ways to better themselves and the world around them. Copyrighted podcast solely owned by the Authors on the Air Global Radio Network, LLC. Follow Shannon on Twitter: @MsShannonFisher.

Dr. Jeanine Cook-Garard talks about Low Vision Awareness & the National Eye Institute. If you’ve been suffering from vision issues, listen to Dr. Mark E. Wilkinson, an optometrist and a Clinical Professor with the University of Iowa. He is also Chair of the Low Vision Subcommittee of the National Eye Health Education Program at the National Eye Institute. He is the author of research articles published in Optometry, the Journal of the American Optometric Association. He also co-authored ‘Protect Your Sight: How to Save Your Vision in the Epidemic of Age-Related Macular Degeneration.

Dr. Jeanine Cook-Garard talks about Low Vision Awareness & the National Eye Institute. If you’ve been suffering from vision issues, listen to Dr. Mark E. Wilkinson, an optometrist and a Clinical Professor with the University of Iowa. He is also Chair of the Low Vision Subcommittee of the National Eye Health Education Program at the National Eye Institute. He is the author of research articles published in Optometry, the Journal of the American Optometric Association. He also co-authored ‘Protect Your Sight: How to Save Your Vision in the Epidemic of Age-Related Macular Degeneration.

In honor of Healthy Vision Month, this week Shannon Fisher will interview The National Eye Institute's Dr. Rachel Bishop about eye health, common eye problems, and how we can take better care of our eyes in a preventative manner. Dr. Bishop is the Chief of the Consult Service Section of the Office of the Clinical Director at the National Eye Institute, part of the National Institutes of Health, which is part of the Department of Health and Human Services. She performs eye examinations on patients who are participating in clinical trials throughout the many Institutes and Centers at the National Institutes of Health. Dr. Bishop received her medical degree from the University of Pennsylvania School of Medicine. She completed her medical internship and ophthalmology residency at Walter Reed Army Center. She holds a Master’s of Public Health from Johns Hopkins. She also has a distinguished military career and provided eye care to thousands of soldiers before or after their deployment to Afghanistan and Iraq, as chief of ophthalmology at Darnall Army Community Hospital in Fort Hood, Texas. The Authentic Woman is a weekly radio show hosted by women's rights leader Shannon Fisher offering perspectives on the female experience in America. The show delves deeply into the worlds of writers, artists, celebrities, and community leaders. Follow Shannon on Twitter: https://twitter.com/MsShannonFisher Copyrighted podcast solely owned by the Authors on the Air Global Radio Network, LLC.

What's so great about the human eye? Can we build something just like it? When would we need to design something better? Sadhan joins the podcast again as we give our engineers' perspectives on these questions and more. Related to this episode: • Curriculum for Biomedical Engineering at Northwestern University: http://www.mccormick.northwestern.edu/biomedical/undergraduate/bachelor-of-science/curriculum.html • Ohm's Law, on Wikipedia: https://en.wikipedia.org/wiki/Ohm%27s_law • Anatomy of the eye, at the National Eye Institute: https://nei.nih.gov/photo/anatomy-of-eye • The occipital lobe of the brain, on Wikipedia: https://en.wikipedia.org/wiki/Occipital_lobe • Focal length, at Nikon: https://www.nikonusa.com/en/learn-and-explore/a/tips-and-techniques/understanding-focal-length.html • Myopia, at the National Eye Institute: https://nei.nih.gov/health/errors/myopia • Macro lenses in photography, at Techradar: https://www.techradar.com/how-to/what-is-a-macro-lens-magnification-and-minimum-focus-explained • Algorithms for focusing cameras, at Stanford: https://graphics.stanford.edu/courses/cs178/applets/autofocusPD.html • Magic Eye stereogram images: http://www.magiceye.com/ • Hubble Telescope: http://hubblesite.org/ • Biological taxonomies, on Wikipedia: https://en.wikipedia.org/wiki/Taxonomy_(biology) • “Uncanny valley: robots so creepy they'll haunt your dreams” on Science Focus: http://www.sciencefocus.com/article/future/uncanny-valley-creepy-robots-will-haunt-your-dreams • “The dawn of social robots” at the American Psychological Association's Monitor on Psychology: http://www.apa.org/monitor/2018/01/cover-social-robots.aspx • Terminator 2: Judgment Day, on Rotten Tomatoes: https://www.rottentomatoes.com/m/terminator_2_judgment_day/ Our closing music is “Yes And” by Steve Combs, used under a Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ Subscribe and find more podcast information at: http://www.k12engineering.net. Support Pios Labs with regular donations on Patreon: https://www.patreon.com/pioslabs, or send one-time contributions by buying us coffee: https://ko-fi.com/pioslabs. Thanks to our donors and listeners for making the show possible. The K12 Engineering Education Podcast is a production of Pios Labs: http://www.pioslabs.com.

Guest Dr. Kapil Bharti is a Principal Investigator at the National Eye Institute at the NIH.  His work involves performing translational research on degenerative eye diseases using induced pluripotent stem cell technology. Dr. Bharti’s group…

Rob Weichbrod has been ensuring the welfare of laboratory animals for 40 years. As Chief of Animal Program Administration at the National Eye Institute, he sings the praises of a group of people who have become surprisingly helpful in doing tasks that others won't do. He explained his discovery of the potential he's found in those with intellectual and developmental disabilities (IDD) on Federal Drive with Tom Temin.

Dr. Emily Chew of the National Eye Institute at the National Institutes of Health joins Jay to discuss age-related macular degeneration and the utility of genetic testing to guide the use of vitamin therapy.

This story is about Olivia Penna. Olivia was diagnosed with Stargardt disease at the age of 14. She talks about school. We hear how her family came to terms with her vision impairment. She tells us about university. She talks about raising her daughter Lulu. She's had some great experiences. She's also had some challenges.  Tune in to episode 10 of the Stories Of You Podcast - About Olivia. Our definition of Stargardts used in the episode was taken from the National Eye Institute website: https://nei.nih.gov/health/stargardt/star_facts

On February 28, the National Eye Institute will host a webinar to introduce its 3D Retina Organoid Challenge. Its objective is simple: use $1 million in prize money to encourage researchers from multiple disciplines to create a critical tool for retinal research. The NEI’s Jessica Mazerik and Steve Becker share the details, which can also be found here.

A conversation with Dr. Emily Chew, deputy director of the Division of Epidemiology and Clinical Applications and the deputy clinical director at the National Eye Institute at the National Institutes of Health. Dr. Chew directs studies about the links between diet and macular degeneration. She talks about those findings and other advances in the field.

Old Drugs, New Tricks: Putting an End to Traditional Eye Drops Presenter: Morgan Fedorchak Director  Ophthalmic Biomaterials Laboratory   Glaucoma is the second leading cause of blindness worldwide, expected to affect up to 3 million Americans by 2020. One of the main risk factors in glaucoma is an unsafe increase in intraocular pressure (IOP).  IOP reduction in patients with glaucoma is typically accomplished through the administration of medicated eye drops several times daily, the difficult and frequent nature of which contributes to patient adherence rates estimated to be as low as 30%.  Newer drug delivery methods for glaucoma aimed at improving patient adherence require clinician administration of invasive injections or implants. This talk will encompass the rational design and testing of a variety of controlled release systems for delivery of ocular drugs as well as the many significant considerations for translating these technologies to the clinic where they may benefit patients. In particular, discussion will focus on our team’s development of a completely unique formulation that provides one month of therapeutic levels of glaucoma medication from a noninvasive eye drop. We believe that this new treatment method may have the ability to overcome the issues inherent to traditional eye drop medication while avoiding the need for more invasive techniques.   Morgan Fedorchak is an Assistant Professor of Ophthalmology, Chemical Engineering, and Clinical and Translational Science at the University of Pittsburgh and the director of the Ophthalmic Biomaterials Laboratory. She attended Carnegie Mellon University where she obtained her B.S. in both Chemical Engineering and Biomedical Engineering in 2006. She later earned her PhD in bioengineering at the University of Pittsburgh in 2011 under Dr. William Federspiel studying hemofiltration and medical devices. Subsequently, she was awarded a fellowship from the Fox Center for Vision Restoration to participate in a collaboration between Dr. Steve Little and Dr. Joel Schuman as a postdoctoral researcher in March of 2011. This work formed the basis for the development of a patent pending drug delivery system for glaucoma that was recently featured in The Wall Street Journal. Her research is currently supported by the National Eye Institute, the Cystinosis Research Foundation, the University of Pittsburgh Center for Medical Innovation, and the Wallace H. Coulter Foundation. Recorded Monday, September 12, 2016 at Carnegie Science Center in Pittsburgh, PA.

Today, our guest is Okihide Hikosaka, a Senior Researcher and Section Chief at the National Eye Institute, at the National Institutes of Health in Bethesda, Maryland. We'll be speaking with him about the role of speculation and intuition in science, the life histories and personalities of our monkey colleagues, and how short-term versus long-term memories inhabit different parts of the basal ganglia.

For this episode of Critical Issues in Eyecare: An MD/OD Conversation, we feature a conversation with one of the world's experts in myopia control, Dr. Jeff Waline from The Ohio State University. The myopia epidemic is an an incredibly hot topic in vision care. And we are lucky to have had this opportunity to talk to Dr. Walline.    These are some of the questions that hosts Nate Bonilla-Warford, OD and Mitchel Jackson, MD, ask him   1. Some doctors feel that the 'myopia epidemic' is due to increased detection of myopia. What evidence do you share with them to persuade them that there is an increase in myopia? 2. What are the causes of the this increase? 3. What are the most effective methods of myopia control? Which is most commonly employed? 4. What forms of myopia control fair the best in terms of rebound after cessation of treatment? 5. How beneficial is myopia control if the child still has to wear glasses or contact lenses to be able to see? 6. Do you anticipate sending kids for collagen crosslinking once FDA approved? 7. What's in the works regarding the study of soft multifocal contacts for myopia control? What are some research/papers that will be coming out on this topic?    About Dr. Walline:   Jeffrey J. Walline, OD PhD received his Doctor of Optometry degree from the University of California, Berkeley School of Optometry in 1996, and he received a Master’s degree in Physiological Optics from The Ohio State University College of Optometry in 1998. He completed a PhD degree in Vision Science from The Ohio State University College of Optometry in 2002. Dr. Walline has conducted several pediatric contact lens studies to evaluate the effect of contact lens wear on myopia progression and children's self-perceptions. Dr. Walline is the Chair of the Bifocal Lenses In Nearsighted Kids (BLINK) Study, a multicenter randomized clinical trial enrolling nearly 300 children that is sponsored by the National Eye Institute. He also teaches Vision of Children and Specialty Contact Lenses to third year optometry students. Dr. Walline also founded the Kids Contact Lens Clinic at the Ohio State University College of Optometry. He examines patients and provides contact lens care and myopia control to young children.    

What if you could get in on the ground floor of an $18 billion dollar industry and do it at a $200 million dollar company?Job Seekers should pay special attention to this interview with a successful pioneer in the prescription eye care space. Watch out Warby Parker, you're way behind.According to the National Eye Institute, 64% of people wear glasses in the US which represents over 200 million people.Listen as Roger explains why the Wal-Mart, Costco, Pearl Visions and more will become far less dominant in this huge market.

What if you could get in on the ground floor of an $18 billion dollar industry and do it at a $200 million dollar company?Job Seekers should pay special attention to this interview with a successful pioneer in the prescription eye care space. Watch out Warby Parker, you're way behind.According to the National Eye Institute, 64% of people wear glasses in the US which represents over 200 million people.Listen as Roger explains why the Wal-Mart, Costco, Pearl Visions and more will become far less dominant in this huge market.

It may not be well-known but, according to the National Eye Institute, May is Healthy Vision Month. We thought we would help spread the word and enjoy some good music at the same time. Here's what the National Eye Institute wants to tell you: "Millions of people living in the United States have undetected vision problems, eye diseases, and conditions. HVM is designed to elevate vision as a health priority for the Nation by promoting the importance of early detection and treatment, as well as the use of proper eye safety practices, in preventing vision loss and blindness. One of the most important things people can do to protect their vision is to schedule a comprehensive dilated eye exam. In this painless procedure, an eye care professional examines the eyes to look for common vision problems and eye diseases, many of which have no early warning signs. A comprehensive dilated eye exam can detect eye diseases and conditions in their early stages, before vision loss occurs. Early detection and treatment can help to save your sight." With that said, we thought we'd celebrate Healthy Vision Month by spinning some songs that refer, in the title, to sight/vision is some form. Here we go. After deciding on the title for this episode, Chris' first choice came very easily. From 1977's Draw the Line album, we kick things off with Aerosmith performing 'Sight for Sore Eyes.' Aaron starts his sight-related picks with a track from the oft-overlooked 1995 release from Dokken; Dysfunctional. This album marked the return of George Lynch. We spin the opening track, 'Inside Looking Out.' Electric Six Chris decided to do some digging in research for this episode. A nugget was found in the vast space that is youtube with his choice of the track 'Night Vision' off Electric Six's 2005 release Switzerland. Aaron's next pick is 'Eyes of a Strager.' Wait, before you think it's the well-known Queensryche track, think again. This great sing comes from the appropriately-titled Visual Lies album from Lizzy Borden and is a great addition to the show. We return from break one with a selection from Motley Crue's debut album Too Fast for Love. While filled with lots of great hook-y songs, Too Fast....sports one track that fits in with our vision-themed show as we spin 'Starry Eyes.' Up next is Aaron's choice of a bonus track from Ozzy Osbourne's iconic Blizzard of Oz release. Featuring some seering Randy Rhoads guitar work, 'You Lookin' at Me, Lookin' at You' is a testimony to the strength of material being created by the gone-too-soon guitarist and the Prince of Darkness. Chris keeps the Crazy Train on track as we segue into a double-dose of Ozzy with his choice of 'Looking for Tomorrow' from the classic Sabbath Bloody Sabbath album from 1973. One band that doesn't get nearly the amount of recognition it deserves is Turbonegro. We try to alleviate that problem with Aaron's choice of 'If You See Kaye' from their Party Animals album. We close out the show with Chris' choice of a KISS track that appeared on two different albums in the band's catalog with different personnel. 'See You in Your Dreams' was selected from Rock and Roll Over and features some powerful drumming from Peter Criss and a great solo from Ace Frehley. Playing things out this week is a fantastic cover of a sight-related classic that's all about focus. Aaron's choice of At Vance's version of 'Eye of the Tiger' is a motivating way to finish things off. Buy Music! Aerosmith Dokken Electric Six Lizzy Borden Motley Crue Ozzy Osbourne Black Sabbath Turbonegro KISS At Vance Contact Us!   Rate, Review, and Subscribe in iTunes Join the Fan Page Follow on Twitter E-mail Us Comment Below   Call us on the Hotline! (540) DBGeek - 1 or (540) 342-3351 

Regenerative Medicine Today welcomes Anand Swaroop, PhD. Dr. Swaroop is Senior Investigator and Chief at the Neurobiology Neurodegeneration Repair Laboratory, National Eye Institute, National Institutes of Health. Dr. Swaroop discusses his research in retinal and macular diseases and the progress his lab has made in the field. For more information about Dr.Swaroop, click [...]

Background: In the present study we evaluated the functional success after macular hole surgery in correlation to visual quality of life and looked for predictive factors determining surgical success.Methods: Fifty-nine patients that underwent pars plana vitrectomy for idiopathic macular hole were included. Follow-up visits were performed in regular intervals after surgery and included a clinical examination, optical coherence tomography (OCT) and measurement of visual acuity. To assess the visual quality of life patients filled out the National Eye Institute 25-item Visual Function Questionnaire (VFQ-25) before and three months and one year after surgery.Results: Macular hole closure was achieved in 57 of 59 patients (97%). Mean visual acuity increased from 20/100 preoperatively to 20/34 one year after surgery (p = 0.02). Despite good visual acuity (20/27) in the fellow eye, visual quality of life (VFQ composite score) rose from 75.9 ± 14.4 (SD) to 81.5 ± 14.2 one year after surgery (p